Erasca Statistics
NASDAQ: ERASHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.61-0.61 (-4.29%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Erasca by the numbers
Erasca has a market capitalization of $4.78 billion based on 350.96M shares outstanding. With trailing EPS of $-0.97, Erasca is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 7.8% below its 50-day average and 11.2% below its 200-day average.
Average daily trading volume is 5.27M shares, or about $71.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ERAS valuation vs. peer median
| Metric | ERAS | Peer median | Difference |
|---|---|---|---|
| Market cap | $4.78B | $4.74B | +1% |
| Avg. volume | 5.27M | 1.44M | +265% |
Peer median across 8 companies: DNTH, PTCT, LQDA, COGT, TVTX, MANE, IONS, BLTE.
Valuation
- Market cap
- $4.78B
- EPS (TTM)
- $-0.97
- Shares outstanding
- 350.96M
Price and trading
- Previous close
- 14.22
- Open
- 13.13
- Day range
- 13.13 – 14.31
- 52-week range
- 2.81 – 24.28
- 52-week change
- +366.10%
- Beta
- —
- Volume
- 11.07M
- Average volume
- 5.27M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 4.78B
- Forward Pe
- -17.36
- Eps
- -0.97
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.28
- Week52 Low
- 2.81
- Avg Volume
- 5.27M
- Shares Outstanding
- 350.96M
- Ma50
- 14.77
- Ma200
- 15.33
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -43.95%
- Pct From52w Low
- 384.34%